Works by Shimose, Takayuki

Results: 21

Prophylactic Effect of Dexamethasone on Regorafenib-Related Fatigue and/or Malaise: A Randomized, Placebo-Controlled, Double-Blind Clinical Study in Patients with Unresectable Metastatic Colorectal Cancer (KSCC1402/HGCSG1402).

Published in:

Oncology, 2018, v. 94, n. 5, p. 289, doi. 10.1159/000486624

By:

Tanioka, Hiroaki;
Miyamoto, Yuji;
Tsuji, Akihito;
Asayama, Masako;
Shiraishi, Takeshi;
Yuki, Satoshi;
Kotaka, Masahito;
Makiyama, Akitaka;
Shimokawa, Mototsugu;
Shimose, Takayuki;
Masuda, Satohiro;
Yamaguchi, Takuhiro;
Komatsu, Yoshito;
Saeki, Hiroshi;
Emi, Yasunori;
Baba, Hideo;
Oki, Eiji;
Maehara, Yoshihiko

Publication type:

Article

Exploration of resistance mechanisms for epidermal growth factor receptor‐tyrosine kinase inhibitors based on plasma analysis by digital polymerase chain reaction and next‐generation sequencing.

Published in:

Cancer Science, 2018, v. 109, n. 12, p. 3921, doi. 10.1111/cas.13820

By:

Iwama, Eiji;
Sakai, Kazuko;
Azuma, Koichi;
Harada, Daijiro;
Nosaki, Kaname;
Hotta, Katsuyuki;
Nishio, Makoto;
Kurata, Takayasu;
Fukuhara, Tatsuro;
Akamatsu, Hiroaki;
Goto, Koichi;
Shimose, Takayuki;
Kishimoto, Junji;
Nakanishi, Yoichi;
Nishio, Kazuto;
Okamoto, Isamu

Publication type:

Article

A phase I/II study of S-1 and irinotecan (IRIS) combined with cetuximab in patients with RAS wild-type metastatic colorectal cancer (KSCC1401).

Published in:

Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 2, p. 285, doi. 10.1007/s00280-020-04108-x

By:

Samura, Hironori;
Oki, Eiji;
Okumura, Hiroshi;
Yoshida, Takefumi;
Kai, Seiichiro;
Kobayashi, Kazuma;
Kinjo, Tatsuya;
Mori, Shinichiro;
Tohyama, Tetsuo;
Ohgaki, Kippei;
Kawanaka, Hirofumi;
Makiyama, Akitaka;
Ureshino, Norio;
Kotaka, Masahito;
Shimose, Takayuki;
Ando, Koji;
Saeki, Hiroshi;
Baba, Hideo;
Maehara, Yoshihiko;
Mori, Masaki

Publication type:

Article

Rationale and design of phase II clinical trial of dual inhibition with ramucirumab and erlotinib in EGFR exon 19 deletion-positive treatment-naïve non-small cell lung cancer with high PD-L1 expression (SPIRAL-3D study).

Published in:

Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231177022

By:

Kawachi, Hayato;
Yamada, Tadaaki;
Yoshimura, Akihiro;
Morimoto, Kenji;
Iwasaku, Masahiro;
Tokuda, Shinsaku;
Kim, Young Hak;
Shimose, Takayuki;
Takayama, Koichi

Publication type:

Article

Longitudinal monitoring of somatic genetic alterations in circulating cell-free DNA during treatment with epidermal growth factor receptor-tyrosine kinase inhibitors.

Published in:

2020

By:

Iwama, Eiji;
Sakai, Kazuko;
Hidaka, Noriko;
Inoue, Koji;
Fujii, Akiko;
Nakagaki, Noriaki;
Ota, Keiichi;
Toyozawa, Ryo;
Azuma, Koichi;
Nakatomi, Keita;
Harada, Taishi;
Hisasue, Junko;
Sakata, Shinya;
Shimose, Takayuki;
Kishimoto, Junji;
Nakanishi, Yoichi;
Nishio, Kazuto;
Okamoto, Isamu

Publication type:

journal article

Current state of yusho and prospects for therapeutic strategies.

Published in:

Environmental Science & Pollution Research, 2018, v. 25, n. 17, p. 16472, doi. 10.1007/s11356-017-0833-1

By:

Mitoma, Chikage;
Uchi, Hiroshi;
Tsukimori, Kiyomi;
Todaka, Takashi;
Kajiwara, Jumboku;
Shimose, Takayuki;
Akahane, Manabu;
Imamura, Tomoaki;
Furue, Masutaka

Publication type:

Article

Comparison of computed tomography imaging analyses for evaluation after chemotherapy in patients with colorectal cancer: a retrospective pooled analysis of six phase II clinical trials.

Published in:

International Journal of Clinical Oncology, 2019, v. 24, n. 11, p. 1397, doi. 10.1007/s10147-019-01509-8

By:

Hirose, Kosuke;
Oki, Eiji;
Shimose, Takayuki;
Sakamoto, Sanae;
Sasaki, Shun;
Jogo, Tomoko;
Hu, Qingjiang;
Tsuda, Yasuo;
Ando, Koji;
Nakashima, Yuichiro;
Saeki, Hiroshi;
Mori, Masaki

Publication type:

Article

Skeletal muscle loss during systemic chemotherapy for colorectal cancer indicates treatment response: a pooled analysis of a multicenter clinical trial (KSCC 1605-A).

Published in:

International Journal of Clinical Oncology, 2019, v. 24, n. 10, p. 1204, doi. 10.1007/s10147-019-01460-8

By:

Sasaki, Shun;
Oki, Eiji;
Saeki, Hiroshi;
Shimose, Takayuki;
Sakamoto, Sanae;
Hu, Qingjiang;
Kudo, Kensuke;
Tsuda, Yasuo;
Nakashima, Yuichiro;
Ando, Koji;
Akagi, Yoshito;
Kakeji, Yoshihiro;
Baba, Hideo;
Maehara, Yoshihiko

Publication type:

Article

A prospective study of XELIRI plus bevacizumab as a first-line therapy in Japanese patients with unresectable or recurrent colorectal cancer (KSCC1101).

Published in:

International Journal of Clinical Oncology, 2017, v. 22, n. 5, p. 913, doi. 10.1007/s10147-017-1140-z

By:

Ando, Koji;
Emi, Yasunori;
Suenaga, Toyokuni;
Hamanoue, Masahiro;
Maekawa, Soichiro;
Sakamoto, Yasuo;
Kai, Seiichiro;
Satake, Hironaga;
Shimose, Takayuki;
Shimokawa, Mototsugu;
Saeki, Hiroshi;
Oki, Eiji;
Sakai, Kenji;
Akagi, Yoshito;
Baba, Hideo;
Maehara, Yoshihiko

Publication type:

Article

Phase II Trial on Osimertinib as a First-Line Treatment for EGFR Mutation-Positive Advanced NSCLC in Elderly Patients: The SPIRAL-0 Study.

Published in:

Oncologist, 2022, v. 27, n. 11, p. 903, doi. 10.1093/oncolo/oyac193

By:

Chihara, Yusuke;
Takeda, Takayuki;
Goto, Yasuhiro;
Nakamura, Yoichi;
Tsuchiya-Kawano, Yuko;
Nakao, Akira;
Onoi, Keisuke;
Hibino, Makoto;
Fukuda, Minoru;
Honda, Ryoichi;
Yamada, Takahiro;
Taniguchi, Ryusuke;
Sakamoto, Sinjiro;
Date, Koji;
Nagashima, Seiji;
Tanzawa, Shigeru;
Minato, Koichi;
Nakatani, Koichi;
Izumi, Miiru;
Shimose, Takayuki

Publication type:

Article

Erlotinib for Non‐Small Cell Lung Cancer with Leptomeningeal Metastases: A Phase II Study (LOGIK1101).

Published in:

Oncologist, 2020, v. 25, n. 12, p. e1869, doi. 10.1634/theoncologist.2020-0640

By:

Nosaki, Kaname;
Yamanaka, Takeharu;
Hamada, Akinobu;
Shiraishi, Yoshimasa;
Harada, Taishi;
Himeji, Daisuke;
Kitazaki, Takeshi;
Ebi, Noriyuki;
Shimose, Takayuki;
Seto, Takashi;
Takenoyama, Mitsuhiro;
Sugio, Kenji

Publication type:

Article

Survival Analysis for Patients with ALK Rearrangement‐Positive Non‐Small Cell Lung Cancer and a Poor Performance Status Treated with Alectinib: Updated Results of Lung Oncology Group in Kyushu 1401.

Published in:

Oncologist, 2020, v. 25, n. 4, p. 306, doi. 10.1634/theoncologist.2019-0728

By:

Iwama, Eiji;
Goto, Yasushi;
Murakami, Haruyasu;
Tsumura, Shinsuke;
Sakashita, Hiroyuki;
Mori, Yoshiaki;
Nakagaki, Noriaki;
Fujita, Yuka;
Seike, Masahiro;
Bessho, Akihiro;
Ono, Manabu;
Nishitsuji, Masaru;
Akamatsu, Hiroaki;
Morinaga, Ryotaro;
Akagi, Takanori;
Shimose, Takayuki;
Tokunaga, Shoji;
Yamamoto, Nobuyuki;
Nakanishi, Yoichi;
Sugio, Kenji

Publication type:

Article

Clarithromycin Plus Intravenous Immunoglobulin Therapy Can Reduce the Relapse Rate of Kawasaki Disease: A Phase 2, Open-Label, Randomized Control Study.

Published in:

Journal of the American Heart Association, 2017, v. 6, n. 7, p. 1, doi. 10.1161/JAHA.116.005370

By:

Etsuro Nanishi;
Hisanori Nishio;
Hidetoshi Takada;
Kenichiro Yamamura;
Mitsuharu Fukazawa;
Kenji Furuno;
Yumi Mizuno;
Kenjiro Saigo;
Ryo Kadoya;
Noriko Ohbuchi;
Yasuhiro Onoe;
Hironori Yamashita;
Hideki Nakayama;
Takuya Hara;
Takuro Ohno;
Yasuhiko Takahashi;
Ken Hatae;
Tatsuo Harada;
Takayuki Shimose;
Junji Kishimoto

Publication type:

Article

Effects of pericapsular soft tissue and realignment exercises for patients with osteoarthritis of the hip and Harris Hip Score below 60 points.

Published in:

Current Medical Research & Opinion, 2022, v. 38, n. 9, p. 1567, doi. 10.1080/03007995.2022.2088716

By:

Hayashi, Kazuo;
Tsunoda, Toshiharu;
Tobo, Yuki;
Ichikawa, Fumiaki;
Shimose, Takayuki

Publication type:

Article

Forthcoming Phase II Study of Durvalumab (MEDI4736) Plus Chemotherapy for Small Cell Lung Cancer with Brain Metastases.

Published in:

Cancer Management & Research, 2022, v. 14, p. 3449, doi. 10.2147/CMAR.S391220

By:

Shiraishi, Yoshimasa;
Shimose, Takayuki;
Tsuchiya-Kawano, Yuko;
Ishii, Hidenobu;
Daga, Haruko;
Ito, Kentaro;
Saruwatari, Koichi;
Okamoto, Isamu

Publication type:

Article

Phase II study of durvalumab (MEDI 4736) plus carboplatin and etoposide in elderly patients with extensive stage small cell lung cancer: Study protocol of turtle study (LOGIK 2003).

Published in:

Thoracic Cancer, 2023, v. 14, n. 1, p. 105, doi. 10.1111/1759-7714.14727

By:

Ishii, Hidenobu;
Azuma, Koichi;
Shimose, Takayuki;
Yoshioka, Hiroshige;
Kurata, Takayasu;
Shingu, Naoki;
Okamoto, Masaki;
Kawashima, Yosuke;
Okamoto, Isamu

Publication type:

Article

A phase II study of weekly carboplatin and concurrent radiotherapy in older adults with locally advanced non‐small cell lung cancer (LOGIK1902).

Published in:

Thoracic Cancer, 2024, v. 15, n. 29, p. 2128, doi. 10.1111/1759-7714.15444

By:

Harada, Taishi;
Sasaki, Tomonari;
Ishii, Hidenobu;
Takemoto, Shinnosuke;
Hisamatsu, Yasushi;
Saito, Haruhiro;
Yoneshima, Yasuto;
Komiya, Kazutoshi;
Kashiwabara, Kosuke;
Naoki, Katsuhiko;
Ogawa, Tomohiro;
Takeoka, Hiroaki;
Saruwatari, Koichi;
Ito, Kensaku;
Tsuchiya‐Kawano, Yuko;
Mizuno, Keiko;
Shimose, Takayuki;
Shioyama, Yoshiyuki;
Okamoto, Isamu

Publication type:

Article

Cessation of nilotinib in patients with chronic myelogenous leukemia who have maintained deep molecular responses for 2 years: a multicenter phase 2 trial, stop nilotinib (NILSt).

Published in:

2019

By:

Nagafuji, Koji;
Matsumura, Itaru;
Shimose, Takayuki;
Kawaguchi, Tatsuya;
Kuroda, Junya;
Nakamae, Hirohisa;
Miyamoto, Toshihiro;
Kadowaki, Norimitsu;
Ishikawa, Jun;
Imamura, Yutaka;
Yamazaki, Hirohito;
Akashi, Koichi;
Kanakura, Yuzuru

Publication type:

journal article

Efficacy and safety of switching to nilotinib in patients with CML-CP in major molecular response to imatinib: results of a multicenter phase II trial (NILSw trial).

Published in:

2018

By:

Ishikawa, Jun;
Matsumura, Itaru;
Kawaguchi, Tatsuya;
Kuroda, Junya;
Nakamae, Hirohisa;
Miyamoto, Toshihiro;
Matsuoka, Ken-ichi;
Shibayama, Hirohiko;
Hino, Masayuki;
Hirase, Chikara;
Kamimura, Tomohiko;
Shimose, Takayuki;
Akashi, Koichi;
Kanakura, Yuzuru

Publication type:

journal article

Phase II study of carboplatin/nab-paclitaxel/atezolizumab combination therapy for advanced nonsquamous non-small cell lung cancer patients with impaired renal function: RESTART trial.

Published in:

2022

By:

Shiraishi, Yoshimasa;
Kishimoto, Junji;
Shimose, Takayuki;
Toi, Yukihiro;
Sugawara, Shunichi;
Okamoto, Isamu

Publication type:

journal article

Expression of the anaphylatoxin C5a receptor in gastric cancer: implications for vascular invasion and patient outcomes.

Published in:

Medical Oncology, 2016, v. 33, n. 11, p. 1, doi. 10.1007/s12032-016-0834-9

By:

Nitta, Hidetoshi;
Shimose, Takayuki;
Emi, Yasunori;
Imamura, Takahisa;
Ohnishi, Koji;
Kusumoto, Tetsuya;
Yamamoto, Manabu;
Fukuzawa, Kengo;
Takahashi, Ikuo;
Higashi, Hidefumi;
Tsuji, Akihito;
Akagi, Yoshito;
Oki, Eiji;
Maehara, Yoshihiko;
Baba, Hideo

Publication type:

Article